Article, 2024

Effects of Private Equity on Dermatologic Quality of Patient Care

Journal of the European Academy of Dermatology and Venereology, ISSN 1468-3083, 0926-9959, 10.1111/jdv.20191

Contributors

Oscherwitz, Max E 0000-0003-4572-5032 (Corresponding author) [1] Godinich, Brandon M. [2] Patel, Raj H [3] Feldman, Steven 0000-0002-0090-6289 [1] [4]

Affiliations

  1. [1] Wake Forest University
    2. [NORA names: United States; America, North; OECD];
  2. [2] Texas Tech Health Science Center El Paso Paul L. Foster School of Medicine, El Paso, Texas, USA
    3. [NORA names: United States; America, North; OECD];
  3. [3] Edward Via College of Osteopathic Medicine
    4. [NORA names: United States; America, North; OECD];
  4. [4] University of Southern Denmark
    5. [NORA names: SDU University of Southern Denmark; University; Denmark; Europe, EU; Nordic; OECD]

Keywords

Dermatology Quality, care, dermatology, effect, effects of private equity, equity, patient care, private equity, quality of patient care

Funders

  • Novartis (United States)
  • Eli Lilly (United States)
  • National Psoriasis Foundation
  • Samsung (South Korea)
  • Sanofi (United States)
  • Pfizer (United States)
  • Boehringer Ingelheim (United States)
  • Regeneron (United States)
  • Mylan (United States)
  • Sun Pharma (India)

Data Provider: Digital Science

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+